Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICAL INDICATORS INDUSTRY
2.1 Summary about Biological Indicators Industry
2.2 Biological Indicators Market Trends
2.2.1 Biological Indicators Production & Consumption Trends
2.2.2 Biological Indicators Demand Structure Trends
2.3 Biological Indicators Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Self-Contained Biological Indicator 
4.2.2 Biological Indicator Strip
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital 
4.3.2 Pharma Companies 
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Self-Contained Biological Indicator 
5.2.2 Biological Indicator Strip
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital 
5.3.2 Pharma Companies 
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Self-Contained Biological Indicator 
6.2.2 Biological Indicator Strip
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital 
6.3.2 Pharma Companies 
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Self-Contained Biological Indicator 
7.2.2 Biological Indicator Strip
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital 
7.3.2 Pharma Companies 
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Self-Contained Biological Indicator 
8.2.2 Biological Indicator Strip
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital 
8.3.2 Pharma Companies 
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Self-Contained Biological Indicator 
9.2.2 Biological Indicator Strip
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital 
9.3.2 Pharma Companies 
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 3M 
10.1.2 Getinge Group 
10.1.3 Cantel Medical 
10.1.4 Mesa Laboratories 
10.1.5 Steris 
10.1.6 Fuze Medical 
10.1.7 Matachana 
10.1.8 Hu-Friedy 
10.1.9 Advanced Sterilization 
10.1.10 Bag Health Care 
10.1.11 Terragene 
10.1.12 Andersen 
10.1.13 GKE
10.2 Biological Indicators Sales Date of Major Players (2017-2020e)
10.2.1 3M 
10.2.2 Getinge Group 
10.2.3 Cantel Medical 
10.2.4 Mesa Laboratories 
10.2.5 Steris 
10.2.6 Fuze Medical 
10.2.7 Matachana 
10.2.8 Hu-Friedy 
10.2.9 Advanced Sterilization 
10.2.10 Bag Health Care 
10.2.11 Terragene 
10.2.12 Andersen 
10.2.13 GKE
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biological Indicators Product Type Overview
Table Biological Indicators Product Type Market Share List
Table Biological Indicators Product Type of Major Players
Table Brief Introduction of 3M 
Table Brief Introduction of Getinge Group 
Table Brief Introduction of Cantel Medical 
Table Brief Introduction of Mesa Laboratories 
Table Brief Introduction of Steris 
Table Brief Introduction of Fuze Medical 
Table Brief Introduction of Matachana 
Table Brief Introduction of Hu-Friedy 
Table Brief Introduction of Advanced Sterilization 
Table Brief Introduction of Bag Health Care 
Table Brief Introduction of Terragene 
Table Brief Introduction of Andersen 
Table Brief Introduction of GKE
Table Products & Services of 3M 
Table Products & Services of Getinge Group 
Table Products & Services of Cantel Medical 
Table Products & Services of Mesa Laboratories 
Table Products & Services of Steris 
Table Products & Services of Fuze Medical 
Table Products & Services of Matachana 
Table Products & Services of Hu-Friedy 
Table Products & Services of Advanced Sterilization 
Table Products & Services of Bag Health Care 
Table Products & Services of Terragene 
Table Products & Services of Andersen 
Table Products & Services of GKE
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biological Indicators Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biological Indicators Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biological Indicators Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biological Indicators Market Forecast (Million USD) Share by Demand 2021f-2026f